Global Human Insulin Market Insights and Forecast to 2026

Global Human Insulin Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Insulin Product Introduction
1.2 Market Segments
1.3 Key Human Insulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Insulin Market Size Growth Rate by Type
1.4.2 Insulin Analogs and Biosimilars
1.4.3 Human Insulin Biologics
1.5 Market by Application
1.5.1 Global Human Insulin Market Size Growth Rate by Application
1.5.2 Short acting
1.5.3 Intermediate acting
1.5.4 Long acting
1.5.5 Pre-mix Insulin
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Insulin Market Size, Estimates and Forecasts
2.1.1 Global Human Insulin Revenue 2015-2026
2.1.2 Global Human Insulin Sales 2015-2026
2.2 Global Human Insulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Insulin Competitor Landscape by Players
3.1 Human Insulin Sales by Manufacturers
3.1.1 Human Insulin Sales by Manufacturers (2015-2020)
3.1.2 Human Insulin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Insulin Revenue by Manufacturers
3.2.1 Human Insulin Revenue by Manufacturers (2015-2020)
3.2.2 Human Insulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Insulin Revenue in 2019
3.2.5 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Insulin Price by Manufacturers
3.4 Human Insulin Manufacturing Base Distribution, Product Types
3.4.1 Human Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Insulin Product Type
3.4.3 Date of International Manufacturers Enter into Human Insulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Insulin Market Size by Type (2015-2020)
4.1.1 Global Human Insulin Sales by Type (2015-2020)
4.1.2 Global Human Insulin Revenue by Type (2015-2020)
4.1.3 Human Insulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Insulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Insulin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Insulin Revenue Forecast by Type (2021-2026)
4.2.3 Human Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Insulin Market Size by Application (2015-2020)
5.1.1 Global Human Insulin Sales by Application (2015-2020)
5.1.2 Global Human Insulin Revenue by Application (2015-2020)
5.1.3 Human Insulin Price by Application (2015-2020)
5.2 Human Insulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Insulin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Insulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Insulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Insulin by Country
6.1.1 North America Human Insulin Sales by Country
6.1.2 North America Human Insulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Insulin Market Facts & Figures by Type
6.3 North America Human Insulin Market Facts & Figures by Application
7 Europe
7.1 Europe Human Insulin by Country
7.1.1 Europe Human Insulin Sales by Country
7.1.2 Europe Human Insulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Insulin Market Facts & Figures by Type
7.3 Europe Human Insulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Insulin by Region
8.1.1 Asia Pacific Human Insulin Sales by Region
8.1.2 Asia Pacific Human Insulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Insulin Market Facts & Figures by Type
8.3 Asia Pacific Human Insulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Insulin by Country
9.1.1 Latin America Human Insulin Sales by Country
9.1.2 Latin America Human Insulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Insulin Market Facts & Figures by Type
9.3 Central & South America Human Insulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Insulin by Country
10.1.1 Middle East and Africa Human Insulin Sales by Country
10.1.2 Middle East and Africa Human Insulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Insulin Market Facts & Figures by Type
10.3 Middle East and Africa Human Insulin Market Facts & Figures by Application
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Description and Business Overview
11.1.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.1.4 B. Braun Human Insulin Products Offered
11.1.5 B. Braun Related Developments
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Corporation Information
11.2.2 Becton, Dickinson Description and Business Overview
11.2.3 Becton, Dickinson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Becton, Dickinson Human Insulin Products Offered
11.2.5 Becton, Dickinson Related Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description and Business Overview
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Human Insulin Products Offered
11.3.5 Biocon Related Developments
11.4 Biodel
11.4.1 Biodel Corporation Information
11.4.2 Biodel Description and Business Overview
11.4.3 Biodel Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biodel Human Insulin Products Offered
11.4.5 Biodel Related Developments
11.5 ELI Lilly
11.5.1 ELI Lilly Corporation Information
11.5.2 ELI Lilly Description and Business Overview
11.5.3 ELI Lilly Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ELI Lilly Human Insulin Products Offered
11.5.5 ELI Lilly Related Developments
11.6 Julphar
11.6.1 Julphar Corporation Information
11.6.2 Julphar Description and Business Overview
11.6.3 Julphar Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Julphar Human Insulin Products Offered
11.6.5 Julphar Related Developments
11.7 NOVO Nordisk
11.7.1 NOVO Nordisk Corporation Information
11.7.2 NOVO Nordisk Description and Business Overview
11.7.3 NOVO Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 NOVO Nordisk Human Insulin Products Offered
11.7.5 NOVO Nordisk Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Human Insulin Products Offered
11.8.5 Sanofi Related Developments
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Description and Business Overview
11.9.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Wockhardt Human Insulin Products Offered
11.9.5 Wockhardt Related Developments
11.10 Ypsomed
11.10.1 Ypsomed Corporation Information
11.10.2 Ypsomed Description and Business Overview
11.10.3 Ypsomed Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ypsomed Human Insulin Products Offered
11.10.5 Ypsomed Related Developments
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Description and Business Overview
11.1.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
11.1.4 B. Braun Human Insulin Products Offered
11.1.5 B. Braun Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Insulin Market Estimates and Projections by Region
12.1.1 Global Human Insulin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Insulin Revenue Forecast by Regions 2021-2026
12.2 North America Human Insulin Market Size Forecast (2021-2026)
12.2.1 North America: Human Insulin Sales Forecast (2021-2026)
12.2.2 North America: Human Insulin Revenue Forecast (2021-2026)
12.2.3 North America: Human Insulin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Insulin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Insulin Sales Forecast (2021-2026)
12.3.2 Europe: Human Insulin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Insulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Insulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Insulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Insulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Insulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Insulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Insulin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Insulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Insulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Insulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Insulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Insulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Insulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Insulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Human Insulin Market Segments
Table 2. Ranking of Global Top Human Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Insulin Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Insulin Analogs and Biosimilars
Table 5. Major Manufacturers of Human Insulin Biologics
Table 6. Global Human Insulin Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Human Insulin Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Human Insulin Sales by Regions 2015-2020 (K Doses)
Table 9. Global Human Insulin Sales Market Share by Regions (2015-2020)
Table 10. Global Human Insulin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Insulin Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Human Insulin Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin as of 2019)
Table 15. Human Insulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Insulin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Insulin Price (2015-2020) (USD/Dose)
Table 18. Human Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Insulin Product Type
Table 20. Date of International Manufacturers Enter into Human Insulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Insulin Sales by Type (2015-2020) (K Doses)
Table 23. Global Human Insulin Sales Share by Type (2015-2020)
Table 24. Global Human Insulin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Insulin Revenue Share by Type (2015-2020)
Table 26. Human Insulin Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Human Insulin Sales by Application (2015-2020) (K Doses)
Table 28. Global Human Insulin Sales Share by Application (2015-2020)
Table 29. North America Human Insulin Sales by Country (2015-2020) (K Doses)
Table 30. North America Human Insulin Sales Market Share by Country (2015-2020)
Table 31. North America Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Insulin Revenue Market Share by Country (2015-2020)
Table 33. North America Human Insulin Sales by Type (2015-2020) (K Doses)
Table 34. North America Human Insulin Sales Market Share by Type (2015-2020)
Table 35. North America Human Insulin Sales by Application (2015-2020) (K Doses)
Table 36. North America Human Insulin Sales Market Share by Application (2015-2020)
Table 37. Europe Human Insulin Sales by Country (2015-2020) (K Doses)
Table 38. Europe Human Insulin Sales Market Share by Country (2015-2020)
Table 39. Europe Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Insulin Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Insulin Sales by Type (2015-2020) (K Doses)
Table 42. Europe Human Insulin Sales Market Share by Type (2015-2020)
Table 43. Europe Human Insulin Sales by Application (2015-2020) (K Doses)
Table 44. Europe Human Insulin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Insulin Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Human Insulin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Insulin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Insulin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Insulin Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Human Insulin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Insulin Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Human Insulin Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Insulin Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Human Insulin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Insulin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Insulin Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Human Insulin Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Insulin Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Human Insulin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Insulin Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Human Insulin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Insulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Insulin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Insulin Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Human Insulin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Insulin Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Human Insulin Sales Market Share by Application (2015-2020)
Table 69. B. Braun Corporation Information
Table 70. B. Braun Description and Major Businesses
Table 71. B. Braun Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. B. Braun Product
Table 73. B. Braun Recent Development
Table 74. Becton, Dickinson Corporation Information
Table 75. Becton, Dickinson Description and Major Businesses
Table 76. Becton, Dickinson Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Becton, Dickinson Product
Table 78. Becton, Dickinson Recent Development
Table 79. Biocon Corporation Information
Table 80. Biocon Description and Major Businesses
Table 81. Biocon Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Biocon Product
Table 83. Biocon Recent Development
Table 84. Biodel Corporation Information
Table 85. Biodel Description and Major Businesses
Table 86. Biodel Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Biodel Product
Table 88. Biodel Recent Development
Table 89. ELI Lilly Corporation Information
Table 90. ELI Lilly Description and Major Businesses
Table 91. ELI Lilly Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. ELI Lilly Product
Table 93. ELI Lilly Recent Development
Table 94. Julphar Corporation Information
Table 95. Julphar Description and Major Businesses
Table 96. Julphar Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Julphar Product
Table 98. Julphar Recent Development
Table 99. NOVO Nordisk Corporation Information
Table 100. NOVO Nordisk Description and Major Businesses
Table 101. NOVO Nordisk Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. NOVO Nordisk Product
Table 103. NOVO Nordisk Recent Development
Table 104. Sanofi Corporation Information
Table 105. Sanofi Description and Major Businesses
Table 106. Sanofi Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Sanofi Product
Table 108. Sanofi Recent Development
Table 109. Wockhardt Corporation Information
Table 110. Wockhardt Description and Major Businesses
Table 111. Wockhardt Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Wockhardt Product
Table 113. Wockhardt Recent Development
Table 114. Ypsomed Corporation Information
Table 115. Ypsomed Description and Major Businesses
Table 116. Ypsomed Human Insulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Ypsomed Product
Table 118. Ypsomed Recent Development
Table 119. Global Human Insulin Sales Forecast by Regions (2021-2026) (K Doses)
Table 120. Global Human Insulin Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Human Insulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Human Insulin Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Human Insulin Sales Forecast by Country (2021-2026) (K Doses)
Table 124. North America: Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Human Insulin Sales Forecast by Country (2021-2026) (K Doses)
Table 126. Europe: Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Human Insulin Sales Forecast by Region (2021-2026) (K Doses)
Table 128. Asia Pacific: Human Insulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Human Insulin Sales Forecast by Country (2021-2026) (K Doses)
Table 130. Latin America: Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Human Insulin Sales Forecast by Country (2021-2026) (K Doses)
Table 132. Middle East and Africa: Human Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Human Insulin Players
Table 137. Human Insulin Customers List
Table 138. Human Insulin Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 2. Global Human Insulin Sales Market Share by Type in 2020 & 2026
Figure 3. Insulin Analogs and Biosimilars Product Picture
Figure 4. Human Insulin Biologics Product Picture
Figure 5. Global Human Insulin Sales Market Share by Application in 2020 & 2026
Figure 6. Short acting
Figure 7. Intermediate acting
Figure 8. Long acting
Figure 9. Pre-mix Insulin
Figure 10. Human Insulin Report Years Considered
Figure 11. Global Human Insulin Market Size 2015-2026 (US$ Million)
Figure 12. Global Human Insulin Sales 2015-2026 (K Doses)
Figure 13. Global Human Insulin Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Human Insulin Sales Market Share by Region (2015-2020)
Figure 15. Global Human Insulin Sales Market Share by Region in 2019
Figure 16. Global Human Insulin Revenue Market Share by Region (2015-2020)
Figure 17. Global Human Insulin Revenue Market Share by Region in 2019
Figure 18. Global Human Insulin Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Insulin Revenue in 2019
Figure 20. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Human Insulin Sales Market Share by Type (2015-2020)
Figure 22. Global Human Insulin Sales Market Share by Type in 2019
Figure 23. Global Human Insulin Revenue Market Share by Type (2015-2020)
Figure 24. Global Human Insulin Revenue Market Share by Type in 2019
Figure 25. Global Human Insulin Market Share by Price Range (2015-2020)
Figure 26. Global Human Insulin Sales Market Share by Application (2015-2020)
Figure 27. Global Human Insulin Sales Market Share by Application in 2019
Figure 28. Global Human Insulin Revenue Market Share by Application (2015-2020)
Figure 29. Global Human Insulin Revenue Market Share by Application in 2019
Figure 30. North America Human Insulin Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Human Insulin Sales Market Share by Country in 2019
Figure 33. North America Human Insulin Revenue Market Share by Country in 2019
Figure 34. U.S. Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Human Insulin Market Share by Type in 2019
Figure 39. North America Human Insulin Market Share by Application in 2019
Figure 40. Europe Human Insulin Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Human Insulin Sales Market Share by Country in 2019
Figure 43. Europe Human Insulin Revenue Market Share by Country in 2019
Figure 44. Germany Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Human Insulin Market Share by Type in 2019
Figure 55. Europe Human Insulin Market Share by Application in 2019
Figure 56. Asia Pacific Human Insulin Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Human Insulin Sales Market Share by Region in 2019
Figure 59. Asia Pacific Human Insulin Revenue Market Share by Region in 2019
Figure 60. China Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Human Insulin Market Share by Type in 2019
Figure 83. Asia Pacific Human Insulin Market Share by Application in 2019
Figure 84. Latin America Human Insulin Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Human Insulin Sales Market Share by Country in 2019
Figure 87. Latin America Human Insulin Revenue Market Share by Country in 2019
Figure 88. Mexico Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Human Insulin Market Share by Type in 2019
Figure 95. Latin America Human Insulin Market Share by Application in 2019
Figure 96. Middle East and Africa Human Insulin Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Human Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Human Insulin Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Human Insulin Revenue Market Share by Country in 2019
Figure 100. Turkey Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Human Insulin Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Human Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Human Insulin Market Share by Type in 2019
Figure 107. Middle East and Africa Human Insulin Market Share by Application in 2019
Figure 108. North America Human Insulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. North America Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Human Insulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Europe Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Human Insulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Asia Pacific Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Human Insulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Latin America Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Human Insulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Middle East and Africa Human Insulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs